Diabetes Self-Management – FDA reclassified Medtronic’s voluntary June recall of Minimed

medtronic_minimed_paradigm

The recall was initiated because the infusion sets have the potential to cause over- or under-delivery of insulin, which could result in low or high blood glucose levels.

Read more

Posted in Glucose & Insulin